FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/18/2022
Back to search
Official data from USPTO
RIGHTSIGN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
07/18/2022
Classification
Registered
Trademark type
Combined
Nice classes
5, 10
Filing date
06/10/2020
Registration date
01/18/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2022
Last transaction
01/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Yuhang District; Hangzhou; 311100 Zheji, CN
Examiner
TANNER, MICHAEL R
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "RightSign" appearing in stylized font with the depiction of a checkmark above the letter "i" in "Right". The color blue appears in the wording "Right". The color green appears in the wording "Sign" as well as the depiction of the checkmark.
Holders and representatives
Holders
Hangzhou Biotest Biotech Co., Ltd.
Representatives
Kevin O'Keefe Accolade IP Limited
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical-pharmaceutical preparationsPregnancy testing preparationsPharmaceutical preparations for the detection and treatment of infectious diseasesPharmaceutical preparations for the detection and treatment of cardiovascular diseaseMedical diagnostic reagents and assays for testing body fluids for the presences of illicit drugsPharmaceutical preparations for the detection and treatment of immune system related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes for use in testing fertility levelsfor testing for pregnancyfor determining progesterone productionfor testing bodily fluids for the presence of infectious diseasesfor conducting diagnostic urine analysis; chemical preparations for the diagnosis of pregnancy; chemical preparations for medical purposes for diagnosing or detecting infectious diseasesearly stage pregnancytumorsdrug usein-vitro ovulation; chemical preparations for pharmaceutical purposesPregnancy testing preparationsPharmaceutical preparations for the detection and treatment of infectious diseasesPharmaceutical preparations for the detection and treatment of cardiovascular diseaseMedical diagnostic reagents and assays for testing body fluids for the presences of illicit drugsPharmaceutical preparations for the detection and treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; preparations of microorganisms for medical or veterinary use for use in the treatment and diagnosis of inflammationcancerfertility disorderscardiovascular diseaseinfectious diseases; biological preparations for medical purposes use for use in the treatment and diagnosis of inflammationcancerfertility disorderscardiovascular diseaseinfectious diseases; drugs for medical purposespharmaceutical preparations for the treatment and diagnosis of inflammationcancerfertility disorderscardiovascular diseaseinfectious diseases; diagnostic preparations for medical purposes
Class 10
Massage apparatus; surgical apparatus and instruments; medical apparatus and instruments being a digital polymerase chain reaction (pcr) platform comprising Flow cytometers for medical diagnostic uses for use in detectingdiagnosing and treating cancer and infectious disease and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in detectingdiagnosing and treating cancer and infectious disease; instrument cases fitted for medical instruments and for use by doctors; apparatus for use in medical analysis being a digital polymerase chain reaction (pcr) platform comprising Flow cytometers for medical diagnostic uses for use in pre-natal screenings and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in pre-natal screenings; testing apparatus for medical purposes being a digital polymerase chain reaction (dPCR) platform comprising Flow cytometers for medical diagnostic uses for testing DNA and RNA samples and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids and testing DNA and RNA samples; diagnostic apparatus for medical purposes being a digital polymerase chain reaction (dPCR) platform comprising Flow cytometers for medical diagnostic uses for use in detectingdiagnosing and treating cancer and infectious disease and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in detectingdiagnosing and treating cancer and infectious disease
Publications
History of USPTO decisions and trademark events.
50 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/27/2022
FIMP
FINAL DISPOSITION PROCESSED
06/27/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/10/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/22/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/22/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/14/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/14/2021
GPNX
NOTIFICATION PROCESSED BY IB
11/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2021
PUBO
PUBLISHED FOR OPPOSITION
11/02/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/13/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/13/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/13/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/29/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
08/18/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/18/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
08/18/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/15/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/09/2021
GNFR
FINAL REFUSAL E-MAILED
07/09/2021
CNFR
FINAL REFUSAL WRITTEN
07/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2021
ALIE
ASSIGNED TO LIE
06/09/2021
NREV
NOTICE OF REVIVAL - E-MAILED
03/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/17/2021
PETG
PETITION TO REVIVE-GRANTED
03/17/2021
PROA
TEAS PETITION TO REVIVE RECEIVED
03/17/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/17/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/17/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/17/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/17/2021
RFNT
REFUSAL PROCESSED BY IB
09/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/05/2020
RFRR
REFUSAL PROCESSED BY MPU
08/28/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/15/2020
CNRT
NON-FINAL ACTION WRITTEN
08/14/2020
DOCK
ASSIGNED TO EXAMINER
08/12/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/16/2020
Continuous trademark protection
Get notified about every new filing that threatens RIGHTSIGN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.